REFERENCES
- SCuRy RE, Mark EJ, McNeeEy WF, Ebeling SH. Case records of the Massachusetts GeneraE HospitaL N EngE J Med 1998; 339–12: 831-7.
- Koya MP, Simon MA and Sobway MS. Complications of intra-vesicaE therapy for urotheliaE cancer of the Madder. J UrciE 2006; 175: 2004–2010.
- Babjuk M, OosterEinck W, SyEvester R, Kaasinen E, BöhEe A, PaEou J. Guidelines on Tall (non-musde invasive) Madder cancer. Eu-ropean Association of UrMogy. http://www.uroweb.org/fflead-min/tx_eauguidelines/TaT1%2013Eadder%20Cancer.pdf
- Lafontaine PD, Midclleman BR, Graham SD, Sanders WH. Inci-dence of granuEomatous prostatitis and acid-fast bacilii after intravesicaE BCG therapy. Adull UrMogy 1997; 49: 363–6.
- MatEaga BR, Veys JA, Thacker CC, Assimos DG. Prostate abscess foRowing intravesicaE Bacilius CaEmette-Guerin treatment. J UrciE 2002; 167: 251.
- Aust TR, Massey JA. Tubercu Ear prostatic abscess as a complica-tion of intravesicaE bacilius Calimette-Guerin immunotherapy. Int J UroL 2005; 12: 920–1.
- Borrego Hi, Parra ML, Rivas E JA, Gomez CS, Garcia AJ. PerineaE tubercuEous abscess. Presentation of dinicaE case. Arch Esp UroE 1997; 50: 810–1.